Анализ генетических факторов риска развития гиперплазии эндометрия у женщин с избыточной массой тела и ожирением

1. Cree I.A., White V.A., Indave B.I., Lokuhetty D. Revising the WHO classification: female genital tract tumours. Histopathology. 2020; 76(1): 151-6. https://dx.doi.org/10.1111/his.13977
2. Reed S.D., Newton K.M., Clinton W.L., Epplein M., Garcia R., Allison K. et al. Incidence of endometrial hyperplasia. Am. J. Obstet. Gynecol. 2009; 200(6): 678.e1-678.e6786. https://dx.doi.org/10.1016/j.ajog.2009.02.032
3. Протасова А.Э., Адамян Л.В., Собивчак М.С., Цыпурдеева А.А. Эндометриальная гиперплазия: современные концепции этиопатогенеза. Проблемы репродукции. 2023; 29(4): 75-80.
4. Думановская М.Р., Чернуха Г.Е., Табеева Г.И., Асатурова А.В. Гиперплазия эндометрия: поиск оптимальных решений и стратегий. Акушерство и гинекология. 2021; 4: 23-31.
5. Подзолкова Н.М., Коренная В.В. Современные представления об этиологии, патогенезе и принципах лечения гиперплазии эндометрия. Акушерство и гинекология. 2021; 8: 192-9.
6. Sanderson P.A., Critchley H.O., Williams A.R., Arends M.J., Saunders P.T. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum. Reprod. Update. 2017; 23(2): 232-54. https://dx.doi.org/10.1093/humupd/dmw042
7. Chandra V., Kim J.J., Benbrook D.M., Dwivedi A., Rai R. Therapeutic options for management of endometrial hyperplasia. J. Gynecol. Oncol. 2016; 27(1): e8. https://dx.doi.org/10.3802/jgo.2016.27.e8
8. Пономаренко И.В., Полоников А.В., Чурносов М.И. Гиперпластические процессы эндометрия: этиопатогенез, факторы риска, полиморфизм генов-кандидатов. Акушерство и гинекология. 2019; 1: 13-8.
9. Габидуллина Р.И., Смирнова Г.А., Нухбала Ф.Р., Валеева Е.В., Орлова Ю.И., Шакиров А.А. Гиперпластические процессы эндометрия: современная тактика ведения пациенток. Гинекология. 2019; 21(6): 53-8.
10. Nees L.K., Heublein S., Steinmacher S., Juhasz-Böss I., Brucker S., Tempfer C.B. et al. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch. Gynecol. Obstet. 2022; 306(2): 407-21. https://dx.doi.org/10.1007/s00404-021-06380-5
11. Wise M.R., Gill P., Lensen S., Thompson J.M., Farquhar C.M. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women. Am. J. Obstet. Gynecol. 2016; 215(5): 598.e1-598.e8. https://dx.doi.org/10.1016/j.ajog.2016.06.006
12. Alsudairi H.N., Alrasheed A.T., Dvornyk V. Estrogens and uterine fibroids: an integrated view. Research Results in Biomedicine. 2021; 7(2): 156-63. https://dx.doi.org/10.18413/2658-6533-2021-7-2-0-6
13. Ponomarenko M.S., Reshetnikov E.A., Churnosova M.M., Reshetnikova Y.N., Churnosov V.I., Ponomarenko I.V. Comorbidity and syntropy of benign proliferative diseases of the female reproductive system: non-genetic, genetic, and epigenetic factors (review). Research Results in Biomedicine. 2023; 9(4): 544-56. https://dx.doi.org/10.18413/2658- 6533-2023-9-4-0-9
14. Demakova N.A., Altuchova O.B., Orlova V.S., Pachomov S.P., Krikun E.N. Associations of cytokines genetic polymorphisms with development of endometrial hyperplasia. Research Journal of Pharmaceutical, Biological and Chemical. 2014; 5(5): 1041-5.
15. van der Putten L.J.M., van Hoof R., Tops B.B.J., Snijders M.P.L.M., van den Berg-van Erp S.H., van der Wurff A.A.M. et al. Molecular profiles of benign and (pre)malignant endometrial lesions. Carcinogenesis. 2017; 38(3): 329-35. https://dx.doi.org/10.1093/carcin/bgx008
16. Altuchova O.B., Demakova N.A., Koneva O.A., Pachomov S.P., Orlova V.S., Golovchenko O.V. Genetic factors of uterine hyperplastic processes. Research Journal of Pharmaceutical, Biological and Chemical. 2014; 6(5): 1397-400.
17. Демакова Н.А. Молекулярно-генетические характеристики пациенток с гиперплазией и полипами эндометрия. Научный результат. Медицина и фармация. 2018; 4(2): 26-39.
18. Ivanova T.I., Krikunova L.I., Ryabchenko N.I., Mkrtchyan L.S., Khorokhorina V.A., Salnikova L.E. Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma. Oxid. Med. Cell. Longev. 2015; 2015: 593658. https://dx.doi.org/10.1155/2015/593658
19. Пономаренко И.В., Полоников А.В., Чурносов М.И. Ассоциация полиморфизма rs4986938 гена ESR2 с развитием гиперплазии эндометрия. Акушерство и гинекология. 2019; 4: 66-72.
20. Фаткуллин И.Ф., Габидуллина Р.И., Смирнова Г.А., Нухбала Ф.Р., Валеева Е.В., Орлова Ю.И., Шакиров А.А. Ассоциация полиморфизма RS2414098 гена CYP19A1 с риском развития гиперплазии эндометрия. Акушерство и гинекология. 2020; 2: 125-30.
21. Ponomarenko I., Reshetnikov E., Polonikov A., Sorokina I., Yermachenko A., Dvornyk V. et al. Candidate genes for age at menarche are associated with endometrial hyperplasia. Gene. 2020; 757: 144933. https://dx.doi.org/10.1016/j.gene.2020.144933
22. Ruth K.S., Campbell P.J., Chew S., Lim E.M., Hadlow N., Stuckey B.G. et al. Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. Eur. J. Hum. Genet. 2016; 24: 284-90. https://dx.doi.org/10.1038/ejhg.2015.102
23. Ruth K.S., Day F.R., Tyrrell J., Thompson D.J., Wood A.R., Mahajan A. et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat. Med. 2020; 26(2): 252-8. https://dx.doi.org/10.1038/s41591-020-0751-5
24. Gudjonsson A., Gudmundsdottir V., Axelsson G.T., Gudmundsson E.F., Jonsson B.G., Launer L.J. et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat. Commun. 2022; 13(1): 480. https://dx.doi.org/10.1038/s41467-021-27850-z
25. Пономарева Т.А. Генетические варианты глобулина, связывающего половые гормоны, и гормональный профиль больных генитальным эндометриозом. Научные результаты биомедицинских исследований. 2025; 11(1): 75-90.
26. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007; 81(3): 559-75. https://dx.doi.org/10.1086/519795
27. Che R., Jack J.R., Motsinger-Reif A.A., Brown C.C. An adaptive permutation approach for genome-wide association study: evaluation and recommendations for use. BioData Min. 2014; 7: 9. https://dx.doi.org/10.1186/1756-0381-7-9
28. Пасенов К.Н. Особенности ассоциаций SHBG-связанных генов с раком молочной железы у женщин в зависимости от наличия наследственной отягощенности и мутаций в генах BRCA1/CHEK2. Научные результаты биомедицинских исследований. 2024; 10(1): 69-88.
29. Yarosh S.L., Kokhtenko E.V., Churnosov M.I., Solodilova M.A., Polonikov A.V. Joint effect of glutathione S-transferase genotypes and cigarette smoking on idiopathic male infertility. Andrologia. 2015; 47(9): 980-6. https://dx.doi.org/10.1111/and.12367
30. Ward L.D., Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016; 44(D1): D877-81. https://dx.doi.org/10.1093/nar/gkv1340
31. GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020; 369(6509): 1318-30. https://dx.doi.org/10.1126/science.aaz1776
32. McGrath I.M., Mortlock S., Montgomery G.W. Genetic regulation of physiological reproductive lifespan and female fertility. Int. J. Mol. Sci. 2021; 22(5): 2556. https://dx.doi.org/10.3390/ijms22052556
33. Burger H.G., Hale G.E., Dennerstein L., Robertson D.M. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause. 2008; 15(4 Pt 1): 603-12. https://dx.doi.org/10.1097/gme.0b013e318174ea4d
34. Hambridge H.L., Mumford S.L., Mattison D.R., Ye A., Pollack A.Z., Bloom M.S. et al. The influence of sporadic anovulation on hormone levels in ovulatory cycles. Hum. Reprod. 2013; 28(6): 1687-94. https://dx.doi.org/10.1093/humrep/det090
35. Ruth K.S., Beaumont R.N., Tyrrell J., Jones S.E., Tuke M.A., Yaghootkar H. et al. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health. Hum. Reprod. 2016; 31(2): 473-81. https://doi.org/10.1093/humrep/dev318
36. Hayes M.G., Urbanek M., Ehrmann D.A., Armstrong L.L., Lee J.Y., Sisk R. et al.; Reproductive Medicine Network. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat. Commun. 2015; 6: 7502. https://dx.doi.org/10.1038/ncomms8502
37. Mbarek H., van de Weijer M.P., van der Zee M.D., Ip H.F., Beck J.J., Abdellaoui A. et al. Biological insights into multiple birth: genetic findings from UK Biobank. Eur. J. Hum. Genet. 2019; 27(6): 970-9. https://dx.doi.org/10.1038/s41431-019-0355-z
38. Pietzner M., Wheeler E., Carrasco-Zanini J., Cortes A., Koprulu M., Wörheide M.A. et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021; 374(6569): eabj1541. https://dx.doi.org/10.1126/science.abj1541
39. Bianco B., Loureiro F.A., Trevisan C.M., Peluso C., Christofolini D.M., Montagna E. et al. Effects of FSHR and FSHB variants on hormonal profile and reproductive outcomes of infertile women with endometriosis. Front. Endocrinol. (Lausanne). 2021; 12: 616. https://dx.doi.org/10.3389/fendo.2021.760616
40. Rull K., Grigorova M., Ehrenberg A., Vaas P., Sekavin A., Nõmmemees D. et al. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women. Hum. Reprod. 2018; 33(5): 954-66. https://dx.doi.org/10.1093/humrep/dey057
41. Trevisan C.M., de Oliveira R., Christofolini D.M., Barbosa C.P., Bianco B. Effects of a polymorphism in the promoter region of the follicle-stimulating hormone subunit beta (FSHB) gene on female reproductive outcomes. Genet. Test. Mol. Biomarkers. 2019; 23(1): 39-44. https://dx.doi.org/10.1089/gtmb.2018.0182
42. Schubert M., Pérez Lanuza L., Wöste M., Dugas M., Carmona F.D., Palomino-Morales R.J. et al. A GWAS in idiopathic/unexplained infertile men detects a genomic region determining follicle-stimulating hormone levels. J. Clin. Endocrinol. Metab. 2022; 107(8): 2350-61. https://dx.doi.org/10.1210/clinem/dgac165
43. Tian Y., Zhao H., Chen H., Peng Y., Cui L., Du Y. et al. Variants in FSHB are associated with polycystic ovary syndrome and luteinizing hormone level in han chinese women. J. Clin. Endocrinol. Metab. 2016; 101(5): 2178-84. https://dx.doi.org/10.1210/jc.2015-3776
44. Saxena R., Bjonnes A.C., Georgopoulos N.A., Koika V., Panidis D., Welt C.K. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume. Hum. Reprod. 2015; 30(7): 1697-703. https://dx.doi.org/10.1093/humrep/dev110

Поступила 19.02.2025

Принята в печать 30.04.2025